Loading insider details...
Beta
Latest Form 4 (Sep 26, 2026): Grant/Award of 2,000 NKTR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 26, 2026 | NEKTAR THERAPEUTICS (NKTR) | Grant/Award | 2,000 | n/a |
| Oct 1, 2025 | NEKTAR THERAPEUTICS (NKTR) | Grant/Award | 8,000 | n/a |
| Nov 20, 2024 | Allovir, Inc. (ALVR) | Sale | 8,706 | $4.8K |
| Nov 6, 2024 | Allovir, Inc. (ALVR) | Sale | 10,609 | $9.2K |
| Oct 23, 2024 | Allovir, Inc. (ALVR) | Sale | 9,752 | $7.6K |
| Oct 4, 2024 | Allovir, Inc. (ALVR) | Sale | 1,493 | $1.2K |
| Aug 22, 2024 | Allovir, Inc. (ALVR) | Sale | 5,390 | $4.0K |
| Aug 20, 2024 | Allovir, Inc. (ALVR) | Sale | 3,091 | $2.3K |
| Aug 7, 2024 | Allovir, Inc. (ALVR) | Sale | 10,847 | $8.0K |
| Jul 23, 2024 | Allovir, Inc. (ALVR) | Sale | 9,731 | $7.3K |